Ketamine is a name that has become increasingly familiar over the years—first as an FDA-approved dissociative anesthetic in surgical and emergency room settings, and more recently as a treatment for depression, anxiety, and PTSD. But what is ketamine made of, really? And how did scientists go from nature to the lab to create this powerful compound?
Let’s explore the journey from natural discovery to pharmaceutical synthesis.
Before ketamine became a lab-based compound, its chemical roots were traced to a natural source. In the mid-20th century, researchers studying fungal metabolites discovered that certain fungi produced molecules with mild anesthetic properties. It was also found that ketamine could be naturally produced by a fungi called Pochonia chlamydosporia, which produced the ketamine molecule to protect itself from parasitic worms.
One fungus with structurally similar properties to ketamine —Streptomyces, a genus known for its antibiotic-producing capabilities—was found to generate compounds with N-methylated amines and cyclic structures, laying conceptual groundwork for the development of synthetic anesthetics. While ketamine used in medical settings is not directly derived from a fungus, the discovery of these fungal molecules influenced scientists looking for safer anesthetics
Today’s medically-administered ketamine is a fully synthetic compound, carefully manufactured in pharmaceutical labs. Through a careful, highly regulated process, these ingredients are transformed into the safe, clinical form known as ketamine hydrochloride (HCl)—the version used in hospitals and mental health settings today.
Here’s how it all comes together:
It’s worth noting that even though the raw ingredients are fairly simple, they’re handled with strict oversight. Laws and safety systems are in place to make sure they’re only used for the right reasons—like helping people through surgery or treating mental health conditions.
Ketamine is what's known as a chiral molecule, meaning it exists in two mirror-image forms: S-ketamine and R-ketamine. These are called enantiomers, and while they share the same chemical formula, they interact differently with the brain.
S-ketamine (also known as esketamine) is considered the more potent enantiomer when it comes to anesthesia and analgesia. It binds more strongly to the NMDA receptor, making it effective at lower doses. This is also the form of ketamine used in Spravato, a nasal spray FDA-approved for use in treating depression and anxiety.
R-ketamine, on the other hand, has a lower affinity for the NMDA receptor but has shown promise in preclinical studies for potentially longer-lasting antidepressant effects with fewer side effects.
Both enantiomers are present in racemic ketamine, the standard formulation used in most clinical settings, which contains a 50/50 mixture of S- and R-ketamine.
Although originally developed as a safer anesthetic alternative, ketamine’s structure has proven versatile, especially dose-dependent. It acts primarily as an NMDA receptor antagonist, which explains its dissociative and analgesic effects. But its exact mechanism in treating depression is still being unraveled—one of the reasons it remains an area of intense scientific interest.
Current findings suggest that chronic stress and depression can damage the connections between brain cells, particularly in areas like the prefrontal cortex, which plays a major role in decision-making, mood, and thought patterns. This disconnection can leave people stuck in cycles of negative thinking and emotional distress.
While research into ketamine’s exact mechanism is ongoing, studies so far show that it appears to quickly restore those lost connections and reduce symptoms of depression in ways traditional antidepressants cannot. According to research from Yale Medicine and the National Institutes of Health (NIH), ketamine works in several powerful ways:
Together, these effects make ketamine a uniquely fast-acting and promising treatment for individuals who haven’t responded to conventional approaches.
From fungal inspiration to pharmaceutical reality, ketamine’s story is a remarkable example of how nature can spark innovation, and how science can refine it into a tool for healing. What began as a curiosity in a protective fungal compound has, through decades of research and careful synthesis, become a clinically powerful option for mental health treatment. Its journey—from the soil to the lab to the human brain—reminds us that the boundaries between natural discovery and modern medicine are often more connected than we think. And in that connection lies the promise of not just treating symptoms, but truly restoring wellness.